Tanta University: Non-alcoholic Fatty Liver Disease trials

The registry lists 12 Non-alcoholic Fatty Liver Disease studies with Tanta University as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 3Phase 4 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease PatientsRecruitingNCT06863376Phase 2
• Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver DiseaseRecruitingNCT06739330
• Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian PatientsRecruitingNCT06503068
• the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.RecruitingNCT05942547Phase 3
• Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNot yet recruitingNCT05731596Phase 3
• Evaluating the Efficacy and Safety of Roflumilast in Patients with NASHCompletedNCT06677788Phase 2
• Ketotifen in Non-Alcoholic Fatty Liver Disease PatientsCompletedNCT05616442Phase 4
• Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic SteatohepatitisStatus unknownNCT05605158Phase 3
• High Oral Loading Dose of Cholecalciferol in Non-Alcoholic Fatty Liver DiseaseCompletedNCT05578404Phase 2
• Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients with HyperuricemiaActive, not recruitingNCT05574036Phase 2
• Comparative Study Between Obeticholic Acid Versus Vitamin E in Patients with Non-alcoholic SteatohepatitisActive, not recruitingNCT05573204Phase 2
• Efficacy and Safety of Montelukast in Non Alcoholic Steatohepatitis (NASH)CompletedNCT04537780Phase 4